Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic

• Main Authors: J. Barceló-Vidal (Author), D. Echeverría-Esnal (Author), N. Carballo (Author), M. De Antonio-Cuscó (Author), X. Fernández-Sala (Author), M. E. Navarrete-Rouco (Author), E. Colominas-González (Author), S. Luque (Author), M. Fuster-Esteva (Author), L. Domingo (Author), M. Sala (Author), X. Duran (Author), S. Grau (Author), O. Ferrández (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Drug-related problems (DRP) are events or circumstances in which drug therapy does or could interfere with desired health outcomes. In December 2019, a new coronavirus, SARS-CoV-2, appeared. Little knowledge about this type of infection resulted in the administration of various drugs w...